PetVivo Holdings, Inc.PETVNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank79
3Y CAGR-32.6%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-32.6%/yr
Quarterly compound
Percentile
P79
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 23.55% |
| Q3 2025 | -23.22% |
| Q2 2025 | -5.05% |
| Q1 2025 | -3.59% |
| Q4 2024 | -20.04% |
| Q3 2024 | 20.04% |
| Q2 2024 | -32.35% |
| Q1 2024 | 147.92% |
| Q4 2023 | -3.84% |
| Q3 2023 | 7.36% |
| Q2 2023 | -2.85% |
| Q1 2023 | -7.16% |
| Q4 2022 | 76.77% |
| Q3 2022 | 95.91% |
| Q2 2022 | -61.73% |
| Q1 2022 | 445.47% |
| Q4 2021 | -70.51% |
| Q3 2021 | -15.01% |
| Q2 2021 | 101.48% |
| Q1 2021 | 124.57% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | -100.00% |
| Q1 2020 | -83.81% |
| Q4 2019 | -33.15% |
| Q3 2019 | 0.00% |
| Q2 2019 | -100.00% |
| Q1 2019 | 20.17% |
| Q4 2018 | -28.20% |
| Q3 2018 | 0.00% |
| Q2 2018 | -100.00% |
| Q1 2018 | 236.89% |
| Q4 2017 | -25.27% |
| Q3 2017 | -6.59% |
| Q2 2017 | -52.89% |
| Q1 2017 | 20.06% |
| Q4 2016 | -39.33% |
| Q3 2016 | 1165.16% |
| Q2 2016 | -75.83% |
| Q1 2016 | -44.40% |